$AXS

Insurers Want a Bigger Slice of the Bank Risk Transfer Boom

Insurers are targeting a 50% increase in significant risk transfer (SRT) deals in 2025, with growth expected in corporate loans and mortgages, according to a survey by the International Association of Credit Portfolio Managers. Insurers protected €4.7 billion of SRT tranches in 2025, up from €2.7 billion in 2024. Banks use SRTs to hedge against loan defaults and free up capital. The Bank of England has raised concerns about unfunded SRTs, which rely on insurers' ability to honor guarantees. Key

Original reporting
Published Aug 27, 2026, 9:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 9:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Insurers Want a Bigger Slice of the Bank Risk Transfer Boom — source image
Decision brief

The 30-second read

$AXSNeutralLow
01

Why it matters

The expanding SRT market may boost premium income for participating insurers while adding credit‑risk exposure, influencing bank capital management.

02

Market read

The projected growth in SRTs could reshape credit risk transfer dynamics, affecting both insurers and banks.

03

What to watch

Potential strain on insurers' balance sheets if loan defaults rise sharply.

Relevance 4/10Novelty 4/10

Background

A survey by the International Association of Credit Portfolio Managers of 14 global insurers/reinsurers shows a projected 50% increase in SRT activity in 2026.

Company-level read

Ticker impact

$AXSNeutralMedium confidence
Context

AXIS Capital is listed as an insurer investing in unfunded SRTs, tying it to the sector’s growth outlook.

Expected impact

Potential modest rally if market expands; watch capital adequacy metrics.

Evidence & confidence

Survey data points to a 50% rise in SRT volume, benefiting participants.

$SANBullishMedium confidence
Context

Banco Santander is cited as a lender that regularly places SRTs with insurers, linking it to the growing market.

Expected impact

Slight bullish bias if SRT demand accelerates.

Evidence & confidence

The article notes Santander’s active role in SRT placements amid sector expansion.

Market effects

The survey suggests a sizable increase in insurer‑backed credit guarantees, potentially reshaping the credit‑risk landscape for banks.

European banks dominate the SRT market (63% of reference portfolios), with growing activity in the U.S. (17%).

If insurers expand SRT participation, it could affect global credit spreads and bank capital ratios.

Counterpoint

Regulatory concerns about insurer guarantees could limit growth and increase systemic risk.

Key entities

  • MunichRe AG

    European reinsurer active in unfunded SRTs.

  • AXA SA

    Global insurer participating in SRT market.

  • AXIS Capital Holdings Ltd

    U.S. insurer investing in credit guarantees.

  • Banco Santander SA

    Lender regularly placing SRTs with insurers.

Related articles

$AXSMedAI 8/10

AXIS Capital (AXS) Adds A High-Performing Excess Liability Book

AXIS Capital (AXS) acquired the renewal rights to DUAL North America's Excess Liability business, which wrote $1.2B in premiums last year. AXIS reported Q2 net income up 16% to $251M, but operating and underwriting income declined. The company's book value per share rose 14.7% YoY to $80.67. AXIS trades at a forward P/E of 7.62.

$SANMed

Buyback programme: transactions 10-16sept

Banco Santander completed a share buyback program from 10-16 September 2026, repurchasing 7.1 million shares for €558.9 million, or 30.6% of the program's maximum investment. This represents 18.2% of outstanding shares as of 2021, according to the bank.

$SANMed

Buyback programme: transactions 3-9Sept

Banco Santander (SAN) reported its share buyback transactions from 3-9 September 2026, totaling €468.98 million, or 25.7% of its buyback program. The bank repurchased 12.8 million shares at an average price of €12.72, representing 18.2% of its outstanding shares as of 2021. Transactions occurred across multiple European exchanges.

$SANMed

Is Banco Santander (BME:SAN) Fairly Valued As It Redeems $1.5b Of Notes?

Banco Santander (BME:SAN) is redeeming $1.5b of senior non-preferred notes ahead of their 2027 maturity. The bank's share price has risen 21.4% in 90 days and 25.5% year-to-date. Analysts' consensus price target is €13.04, with a fair value estimate of €13.04, suggesting a slight undervaluation. The P/E ratio is 14.4x, higher than the European banks average of 12.3x. Investors should consider both risks and potential rewards.

$SANMed

Buyback programme: transactions 27Aug-2Sept

Banco Santander completed a share buyback program from 27Aug to 2Sept, repurchasing 11.4M shares for €305.89M (16.8% of the program's max). This represents 18.1% of outstanding shares as of 2021. The average purchase price varied across trading venues, ranging from €12.50 to €12.76.

$SANMedAI 8/10

Santander formalizes the capital increase by Webster Bank

Banco Santander registered the capital increase deed for its acquisition of Webster Financial Corporation, raising its share capital to 7,509.58 million euros, or 15,019,165,940 shares, up from 164.92 million shares at the end of 2025. The bank's share capital now includes 329.84 million more shares than nine months prior, each with a nominal value of 0.50 euros and one voting right.